Nouvelles

Vendredi 25 mai - samdedi 26 mai, 2018

The symposium is joining forces with the Canadian Connective Tissue Conference (CCTC) directly preceding the symposium in the same venue (May 23-25, 2018).
We have organized a lineup of world-renowned experts that will discuss (and possibly fight over) the question of fibroblastic progeny during tissue repair and fibrosis:
Jeremy Duffield, Giulio Gabbiani, Boris Hinz, Neil Henderson, Yuval Rinkevich, Fabio Rossi, Robert Schwabe, and Fiona Watt.
Register here.


Le symposium a joint forces avec la Canadian Connective Tissue Conference (CCTC) précédant directement le symposium au même endroit (du 23 au 25 mai 2018).
Nous avons invité des experts de renommée mondiale qui discuteront sur la question de la progéniture fibroblastique au cours de la réparation tissulaire et de la fibrose:
Jeremy Duffield, Giulio Gabbiani, Boris Hinz, Neil Henderson, Yuval Rinkevich, Fabio Rossi, Robert Schwabe et Fiona Watt.
Inscription ici.

 

Réseau thématique soutenu par le

 

Newsfeed

Stem Cells News -- ScienceDaily

Read about today's stem cell research including novel stem cell technology and advances in understanding cancer stem cells.
  • Gene controls bone-to-fat ratio in bone marrow
    In an unexpected discovery, researchers have found that a gene previously known to control human metabolism also controls the equilibrium of bone and fat in bone marrow as well as how an adult stem cell expresses its final cell type. The findings could lead to a better understanding of the disruption of bone-to-fat ratio in bone marrow as well as its health consequences, and also point to the gene as a promising therapeutic target in the treatment of osteoporosis and skeletal aging.
  • Engineered cancer cells can fight primary and metastatic cancer
    A new study leverages the power of gene editing, capitalizing on cancer cells' self-homing ability to take a critical step toward using cancer cells to kill cancer.